As a result, CD36 may play a role in linking FA metabolism with mitochondrial oxidative stress and inflammation, as well as be a promising target for reversing hepatic dysfunction in NAFLD. Here, CD36 is linked to metabolic dysfunction-associated steatotic liver disease.